Balancing innovation, access, and profits--market exclusivity for biologics.
Engelberg
Alfred B
AB
Engelberg Foundation, Palm Beach, FL, USA.
Kesselheim
Aaron S
AS
Avorn
Jerry
J
D001688:Biological Products / Q000191:economics; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D016568:Drugs, Generic; D007880:Legislation, Drug; D040541:Marketing / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011306:Prescription Fees; D014481:United States
D001688:Biological Products; D016568:Drugs, Generic